New drug trial targets rare, debilitating muscle disease
NCT ID NCT07103746
Summary
This study is testing whether adding an investigational drug called ublituximab to standard medications helps people with a rare autoimmune muscle disease. It will enroll 30 adults who were recently diagnosed and still have active muscle weakness. The main goal is to see if the combination treatment leads to greater improvement in muscle strength and function after 24 weeks compared to standard treatment alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE DISORDERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Emory University School of Medicine: Division of Rheumatology
NOT_YET_RECRUITINGAtlanta, Georgia, 30322, United States
Contact
-
Johns Hopkins Hospital: Division of Rheumatology
RECRUITINGBaltimore, Maryland, 21244, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Mayo Clinic: Division of Rheumatology
NOT_YET_RECRUITINGRochester, Minnesota, 55905, United States
Contact
-
Northwell Health: Division of Rheumatology and Allergy-Clinical Immunology
NOT_YET_RECRUITINGGreat Neck, New York, 11021, United States
Contact
-
University of Alabama at Birmingham School of Medicine: Division of Clinical Immunology & Rheumatology
NOT_YET_RECRUITINGBirmingham, Alabama, 35233, United States
Contact
-
University of California, Irvine School of Medicine: Division of Rheumatology
NOT_YET_RECRUITINGOrange, California, 92868, United States
Contact
-
University of Chicago, Department of Medicine: Rheumatology
NOT_YET_RECRUITINGChicago, Illinois, 60637, United States
Contact
-
University of Pittsburgh Medical Center: Division of Rheumatology and Clinical Immunology
NOT_YET_RECRUITINGPittsburgh, Pennsylvania, 15261, United States
Contact
-
University of Texas - Houston
NOT_YET_RECRUITINGHouston, Texas, 77030, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.